End Stage Renal Disease (ESRD) Recruiting Phase 3 Trials for Tetraferric tricitrate decahydrate (DB14520)

Also known as: End Stage Renal Disease Patients / End- Stage Renal Disease Patients / Renal Disease, End-Stage / Renal Disease, End Stage / ESRD (End-Stage Renal Disease) / End-Stage Renal Disease / End-Stage Renal Disease (ESRD) / End Stage Renal Diseases / End Stage Renal Disease / Chronic kidney disease (CKD) / Chronic renal failure syndrome (disorder) / Renal failure chronic / Renal failure: [chronic] or [end stage] / Chronic renal failure / Kidney failure chronic / Kidney Failure, Chronic / End stage renal failure / End-stage renal disease (disorder)

IndicationStatusPhase
DBCOND0035540 (End Stage Renal Disease (ESRD))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03984760Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisTreatment
NCT04456803Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisTreatment